chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a dietician and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 33-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.  The patient's past medical history included Alcohol use (last had- Glass of wine 4 days ago, 1 glass of wine once every 2 weeks). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 08-Nov-2020 to an unknown date and FISH OIL for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Dec-2020 and the estimated date of delivery was 05-Oct-2021. On 12-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the second week of the pregnancy. On 12-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Pregnancy test: positive (Positive) Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information provided.  Estimated date of conception was reported as 12-Jan-2021. The patient had established prenatal care and had no complications or acute illness during this pregnancy to date. The patient had previous pregnancy which resulted in live full-term birth on 02-Mar-2018. There was no maternal history of subfertility.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Peripheral swelling
Clinical narrative: left wrist hurt, became swollen and warm; severe pain in his left wrist - feels a lot like a gout flare up; severe pain in his left arm - feels a lot like a gout flare up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in his left arm - feels a lot like a gout flare up), PERIPHERAL SWELLING (left wrist hurt, became swollen and warm) and ARTHRALGIA (severe pain in his left wrist - feels a lot like a gout flare up) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe pain in his left arm - feels a lot like a gout flare up) and ARTHRALGIA (severe pain in his left wrist - feels a lot like a gout flare up). On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (left wrist hurt, became swollen and warm). At the time of the report, PAIN IN EXTREMITY (severe pain in his left arm - feels a lot like a gout flare up), PERIPHERAL SWELLING (left wrist hurt, became swollen and warm) and ARTHRALGIA (severe pain in his left wrist - feels a lot like a gout flare up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect). At the time of the report, VACCINATION COMPLICATION (side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Very limited information regarding this event has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medication included, a blood thinner was reported.   Treatment information was not provided.  Patient stated that the fatigue was due to something else and she is fine now.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: The event outcome has updated to Recovered from Not recovered.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Gait disturbance, Pain
Clinical narrative: Redness; Soreness; Difficulty walking; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PAIN (Soreness) and GAIT DISTURBANCE (Difficulty walking) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L2OA) for COVID-19 vaccination.     No medical history reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ERYTHEMA (Redness), PAIN (Soreness) and GAIT DISTURBANCE (Difficulty walking). At the time of the report, ERYTHEMA (Redness), PAIN (Soreness) and GAIT DISTURBANCE (Difficulty walking) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No relevant concomitant medications were reported.  No treatment.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: fever; chills; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 26-Jan-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). On 27-Jan-2021, VACCINATION SITE PAIN (sore arm), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity
Clinical narrative: Light Headed; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light Headed) and PAIN IN EXTREMITY (Sore Arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DIZZINESS (Light Headed) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, DIZZINESS (Light Headed) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: Asthma issues the same night; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma issues the same night) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ASTHMA (Asthma issues the same night). On 30-Jan-2021, ASTHMA (Asthma issues the same night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Tenderness
Clinical narrative: Redness, inch and a half red area; Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness, inch and a half red area) and TENDERNESS (Tenderness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness, inch and a half red area) and TENDERNESS (Tenderness). The patient was treated with IBUPROFEN at an unspecified dose and frequency; Wound care (He was told to apply ice on the affected area by the doctor) for Erythema and Wound care (He was told to apply ice on the affected area by the doctor) for Tenderness. At the time of the report, ERYTHEMA (Redness, inch and a half red area) and TENDERNESS (Tenderness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Rash
Clinical narrative: Rash on her neck and upper chest and under her breast; Sore Left Arm Post First Dose; Tired Post First Dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm Post First Dose), RASH (Rash on her neck and upper chest and under her breast) and FATIGUE (Tired Post First Dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 030L20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event .    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm Post First Dose) and FATIGUE (Tired Post First Dose). On 09-Jan-2021, the patient experienced RASH (Rash on her neck and upper chest and under her breast). On 07-Jan-2021, PAIN IN EXTREMITY (Sore Left Arm Post First Dose) and FATIGUE (Tired Post First Dose) had resolved. On 10-Jan-2021, RASH (Rash on her neck and upper chest and under her breast) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided    This case was linked to MOD-2021-047747 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Ocular discomfort, Pain in extremity, Paraesthesia
Clinical narrative: eye felt like it was going to pop out; pins and needles like feeling in my right arm; headache of left side; eye begun to hurt,eye felt like it was going to pop out; arm still hurts; A spontaneous report was received from a consumer who was a 65-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced pins and needles like feeling in the right arm., headache on left side, eye begun to hurt, eye felt like it was going to pop out and the arm still hurts.  The patient's medical history was not provided. No relevant concomitant medications were reported.  No relevant lab data was provided by the reporter.  On 12-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 026L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  The patient reported that several days after receiving the vaccine, she began to experience a pins and needles-like feeling in her right arm.  She reported developing a headache on the left side shortly after that.  She stated that her eye began to hurt and eye felt like it was going to pop out.  She stated that it happened every time she laid on her left side but that it would cease when she stood up.  Additionally, she reported that her right arm was still hurting.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, pins and needles like feeling in the right arm., headache on left side, eye begun to hurt, eye felt like it was going to pop out and the arm still hurts, was unknown..; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased
Clinical narrative: CRP elevated; This spontaneous case was reported by a nurse and describes the occurrence of C-REACTIVE PROTEIN INCREASED (CRP elevated) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included SULFABENZAMIDA for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced C-REACTIVE PROTEIN INCREASED (CRP elevated). At the time of the report, C-REACTIVE PROTEIN INCREASED (CRP elevated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medications were not reported.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: fairly mild dizziness; tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (fairly mild dizziness) and FATIGUE (tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced FATIGUE (tired). On 05-Feb-2021, the patient experienced DIZZINESS (fairly mild dizziness). On 02-Feb-2021, FATIGUE (tired) had resolved. On 07-Feb-2021, DIZZINESS (fairly mild dizziness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.  No treatment medications provided by the reporter.   Patient received the second vaccination 3 weeks later with no AE    Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received provided event outcome as recovered and 2nd dose details.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (FEVER) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 01-Feb-2021, the patient experienced PYREXIA (FEVER). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (FEVER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Diarrhoea, Feeling abnormal, Pyrexia
Clinical narrative: she just feels bad; she's been having diarrhea; low grade fever of 100.9°F; experiencing severe abdominal cramps; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves), FEELING ABNORMAL (she just feels bad), DIARRHOEA (she's been having diarrhea) and PYREXIA (low grade fever of 100.9°F) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves) and PYREXIA (low grade fever of 100.9°F). On 03-Feb-2021, the patient experienced DIARRHOEA (she's been having diarrhea). On 05-Feb-2021, the patient experienced FEELING ABNORMAL (she just feels bad). The patient was treated with HYDROXYCHLOROQUINE at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves), FEELING ABNORMAL (she just feels bad), DIARRHOEA (she's been having diarrhea) and PYREXIA (low grade fever of 100.9°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Body temperature: 100.9 (abnormal) 100.9°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Retching
Clinical narrative: she just feels bad; she's been having diarrhea; low grade fever of 100.9°F; experiencing severe abdominal cramps; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves), FEELING ABNORMAL (she just feels bad), DIARRHOEA (she's been having diarrhea) and PYREXIA (low grade fever of 100.9°F) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves) and PYREXIA (low grade fever of 100.9°F). On 03-Feb-2021, the patient experienced DIARRHOEA (she's been having diarrhea). On 05-Feb-2021, the patient experienced FEELING ABNORMAL (she just feels bad). The patient was treated with HYDROXYCHLOROQUINE at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (experiencing severe abdominal cramps), RETCHING (dry heaves), FEELING ABNORMAL (she just feels bad), DIARRHOEA (she's been having diarrhea) and PYREXIA (low grade fever of 100.9°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Body temperature: 100.9 (abnormal) 100.9°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe Headache; A spontaneous report was received from a Consumer concerning a 74-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe headache.  The patient's medical history was not provided. Concomitant medications reported were antibiotics for dental surgery.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient developed severe headache.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, severe headache was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of headache, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Some symptoms I have been having from the vaccine; A spontaneous report was received from a consumer concerning (herself) of an unknown age, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some symptoms I have been having from the vaccine (Adverse event).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received her first of two planned doses of mRNA-1273 (Lot number: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the some symptoms I have been having from the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, some symptoms I have been having from the vaccine was unknown..; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate variability increased, Paraesthesia, Urticaria
Clinical narrative: Heat in ears; Elevated heart rate; Hives on stomach that began to spread; tingly and pinchy sensation all over body externally and internally; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives on stomach that began to spread), PARAESTHESIA (tingly and pinchy sensation all over body externally and internally), FEELING HOT (Heat in ears) and HEART RATE VARIABILITY INCREASED (Elevated heart rate) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included METOPROLOL, ALPRAZOLAM (XANAX), MONTELUKAST SODIUM (SINGULAIR), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced URTICARIA (Hives on stomach that began to spread) and PARAESTHESIA (tingly and pinchy sensation all over body externally and internally). On 01-Feb-2021, the patient experienced FEELING HOT (Heat in ears) and HEART RATE VARIABILITY INCREASED (Elevated heart rate). At the time of the report, URTICARIA (Hives on stomach that began to spread), FEELING HOT (Heat in ears) and HEART RATE VARIABILITY INCREASED (Elevated heart rate) had resolved and PARAESTHESIA (tingly and pinchy sensation all over body externally and internally) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs are Protonic . Treatment  medications are Benadryl , Zyrtec , Steroid Shot , Steroid Pack.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Rash, Rash erythematous, Vaccination site rash
Clinical narrative: Sore arm; Had 4 red spots, dime size rash at injection site; Rash starting from my elbow to wrist; Rash at injection site; Fatigue; Red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist) and VACCINATION SITE RASH (Rash at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), VITAMIN B COMPLEX, NIACIN, CALCIUM, MAGNESIUM, FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) and VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist), VACCINATION SITE RASH (Rash at injection site) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, RASH ERYTHEMATOUS (Red rash), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist), VACCINATION SITE RASH (Rash at injection site) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Sore arm; Had 4 red spots, dime size rash at injection site; Rash starting from my elbow to wrist; Rash at injection site; Fatigue; Red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist) and VACCINATION SITE RASH (Rash at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), VITAMIN B COMPLEX, NIACIN, CALCIUM, MAGNESIUM, FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) and VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist), VACCINATION SITE RASH (Rash at injection site) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, RASH ERYTHEMATOUS (Red rash), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE REACTION (Had 4 red spots, dime size rash at injection site), RASH (Rash starting from my elbow to wrist), VACCINATION SITE RASH (Rash at injection site) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site swelling, Subcutaneous emphysema, Swelling
Clinical narrative: Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder; shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle; swelling at the injection site; headache; Fatigue; pressure on her shoulder 20 min after the vaccine; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event .     On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue). On an unknown date, the patient experienced SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder). The patient was treated with ANASTROZOLE (ARIMIDEX) ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date for dental procedure, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date for For dental procedure, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine) and SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle) had resolved and SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder; shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle; swelling at the injection site; headache; Fatigue; pressure on her shoulder 20 min after the vaccine; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event .     On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue). On an unknown date, the patient experienced SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder). The patient was treated with ANASTROZOLE (ARIMIDEX) ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date for dental procedure, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date for For dental procedure, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine) and SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle) had resolved and SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site warmth
Clinical narrative: circle got really hard; little soreness where the injection site was; about an inch in diameter a red circle appeared; circle felt hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (circle felt hot to the touch), VACCINATION SITE INDURATION (circle got really hard), VACCINATION SITE PAIN (little soreness where the injection site was) and VACCINATION SITE ERYTHEMA (about an inch in diameter a red circle appeared) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (circle felt hot to the touch), VACCINATION SITE INDURATION (circle got really hard), VACCINATION SITE PAIN (little soreness where the injection site was) and VACCINATION SITE ERYTHEMA (about an inch in diameter a red circle appeared). At the time of the report, VACCINATION SITE WARMTH (circle felt hot to the touch), VACCINATION SITE INDURATION (circle got really hard), VACCINATION SITE PAIN (little soreness where the injection site was) and VACCINATION SITE ERYTHEMA (about an inch in diameter a red circle appeared) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant information  provided. No Treatment information  provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, SARS-CoV-2 test positive, Taste disorder
Clinical narrative: Everything tasted funny; aches; chills; felt lousy; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Everything tasted funny), PAIN (aches), CHILLS (chills) and FATIGUE (felt lousy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020 and Seasonal allergy since an unknown date. Concurrent medical conditions included Diabetes. Concomitant products included LOSARTAN, SIMVASTATIN and METFORMIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced TASTE DISORDER (Everything tasted funny), PAIN (aches), CHILLS (chills) and FATIGUE (felt lousy). At the time of the report, TASTE DISORDER (Everything tasted funny), PAIN (aches), CHILLS (chills) and FATIGUE (felt lousy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test positive: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the eventS, a causal relationship cannot be excluded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Hypersensitivity, Ocular hyperaemia, Sneezing, Swelling of eyelid
Clinical narrative: Eyes began to itch; Redness of both eyes; SNEEZING,; WHEEZING; eyes became swollen shut.; Hypersensitivity reaction; This spontaneous case was reported by a nurse and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), SNEEZING (SNEEZING,), WHEEZING (WHEEZING), SWELLING OF EYELID (eyes became swollen shut.) and EYE PRURITUS (Eyes began to itch) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.  Concurrent medical conditions included Hypersensitivity reaction, Urticaria, Contrast media allergy (Hives) since 1985, Drug allergy (Rash and itching) since 1987, Allergy to antibiotic (Rash and itching.) since 1984 and Hypothyroidism since 1994. Concomitant products included DICYCLOMINE [DICYCLOVERINE] for Abdominal spasm, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for GERD, ATORVASTATIN CALCIUM (LIPITOR) and ASA for Prophylaxis, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On 02-Feb-2021 at 4:30 PM, the patient experienced SNEEZING (SNEEZING,), WHEEZING (WHEEZING) and SWELLING OF EYELID (eyes became swollen shut.). On an unknown date, the patient experienced EYE PRURITUS (Eyes began to itch) and OCULAR HYPERAEMIA (Redness of both eyes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 02-Feb-2021 for Adverse event, at a dose of 50 milligram every six hours. On 05-Feb-2021, HYPERSENSITIVITY (Hypersensitivity reaction) had resolved. At the time of the report, SNEEZING (SNEEZING,), WHEEZING (WHEEZING), SWELLING OF EYELID (eyes became swollen shut.), EYE PRURITUS (Eyes began to itch) and OCULAR HYPERAEMIA (Redness of both eyes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Events added, diagnosis added, patient history updated, concomitant medications updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Eyes began to itch; Redness of both eyes; SNEEZING,; WHEEZING; eyes became swollen shut.; Hypersensitivity reaction; This spontaneous case was reported by a nurse and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), SNEEZING (SNEEZING,), WHEEZING (WHEEZING), SWELLING OF EYELID (eyes became swollen shut.) and EYE PRURITUS (Eyes began to itch) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.  Concurrent medical conditions included Hypersensitivity reaction, Urticaria, Contrast media allergy (Hives) since 1985, Drug allergy (Rash and itching) since 1987, Allergy to antibiotic (Rash and itching.) since 1984 and Hypothyroidism since 1994. Concomitant products included DICYCLOMINE [DICYCLOVERINE] for Abdominal spasm, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for GERD, ATORVASTATIN CALCIUM (LIPITOR) and ASA for Prophylaxis, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On 02-Feb-2021 at 4:30 PM, the patient experienced SNEEZING (SNEEZING,), WHEEZING (WHEEZING) and SWELLING OF EYELID (eyes became swollen shut.). On an unknown date, the patient experienced EYE PRURITUS (Eyes began to itch) and OCULAR HYPERAEMIA (Redness of both eyes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 02-Feb-2021 for Adverse event, at a dose of 50 milligram every six hours. On 05-Feb-2021, HYPERSENSITIVITY (Hypersensitivity reaction) had resolved. At the time of the report, SNEEZING (SNEEZING,), WHEEZING (WHEEZING), SWELLING OF EYELID (eyes became swollen shut.), EYE PRURITUS (Eyes began to itch) and OCULAR HYPERAEMIA (Redness of both eyes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Events added, diagnosis added, patient history updated, concomitant medications updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: red patches on her Knee , elbow and face , also in her back,; was very itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (red patches on her Knee , elbow and face , also in her back,) and PRURITUS (was very itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (doxycycline).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced RASH (red patches on her Knee , elbow and face , also in her back,). 25-Jan-2021, the patient experienced PRURITUS (was very itchy). On 25-Jan-2021, RASH (red patches on her Knee , elbow and face , also in her back,) and PRURITUS (was very itchy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details included Antihistaminic on 31Jan2021.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: Issue with her bowels; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Issue with her bowels) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ABDOMINAL DISCOMFORT (Issue with her bowels). At the time of the report, ABDOMINAL DISCOMFORT (Issue with her bowels) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Feb-2021 and was forwarded to Moderna on 05-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Issue with her bowels) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ABDOMINAL DISCOMFORT (Issue with her bowels). At the time of the report, ABDOMINAL DISCOMFORT (Issue with her bowels) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site was aching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site was aching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site was aching). At the time of the report, VACCINATION SITE PAIN (Injection site was aching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided